Effects of hydroalcoholic, methanolic, and hexane extracts of brown algae Sargassum angustifolium on scopolamine-induced memory impairment and learning deficit in rodents
Abstract
Background and purpose: Properties of Alzheimer's disease, can be caused by several reasons and there is no definite treatment for it. We aimed to study the effect of the hydroalcoholic extract, methanolic and n-hexane fractions of brown algae Sargassum angustifolium on memory impairment in mice and rats.
Experimental approach: Hydroalcoholic extract (25, 50, 100, 200 mg/kg), methanolic (20 and 40 mg/kg) and n-hexane (40 and 60 mg/kg) fractions of S. angustifolium were administered for 21 days intraperitoneally before scopolamine injection (2 mg/kg) on day 21. Rivastigmine was administered for 3 weeks intraperitoneally as well. Then, cognitive function was evaluated by three behavioral tests: passive avoidance, object recognition, and the Morris Water Maze test.
Findings/Results: Scopolamine induced memory impairment and rivastigmine significantly reversed the memory dysfunction in all three tests. Hydroalcoholic extract and methanolic fraction significantly reversed scopolamine-induced memory impairment in passive avoidance by 64% and 55% and enhanced the recognition index in the object recognition test. In the Morris water maze test probe trial and training session, on days 3 and 4, the hydroalcoholic extract showed a significant decrease in time spent in the target quadrant and path length, respectively. Also, hydroalcoholic extract and methanolic fraction decreased escape latency time in training sessions on days 3 and 4, by 50% and 31% in comparison to scopolamine. N-hexane fractions had no significant effect on scopolamine-induced cognitive impairment.
Conclusion and implications: Although the n-hexane fraction wasn’t effective, the administration of hydroalcoholic extract and the methanolic fraction of S. angustifolium enhanced scopolamine-induced memory impairment.
Keywords
Full Text:
PDFReferences
Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2):312-339.DOI: 10.1016/j.cell.2019.09.001.
Niu H, Alvarez-Alvarez I, Guillen-Grima F, Aguinaga-Ontoso I. Prevalence and incidence of Alzheimer's disease in europe: a meta-analysis. Neurologia. 2017;32(8):523-532. DOI: 10.1016/j.nrl.2016.02.016.
Amin MJ, Miana GA, Rashid U, Rahman KM, Khan HU, Sadiq A. SAR based in-vitro anticholinesterase and molecular docking studies of nitrogenous progesterone derivatives. Steroids. 2020;158:108599,1-11. DOI: 10.1016/j.steroids.2020.108599.
Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148-160. DOI: 10.1038/s41583-019-0132-6.
Ozben T, Ozben S. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease. Clin Biochem. 2019;72:87-89. DOI: 10.1016/j.clinbiochem.2019.04.001.
Karthivashan G, Park SY, Kweon MH, Kim J, Haque ME, Cho DY, et al. Ameliorative potential of desalted Salicornia europaea L. extract in multifaceted Alzheimer’s-like scopolamine-induced amnesic mice model. Biology. 2018;8(1):1-16. DOI: 10.1038/s41598-018-25381-0.
Sharma K. Cholinesterase inhibitors as Alzheimer's therapeutics. Mol Med Rep. 2019;20(2):1479-1487. DOI: 10.3892/mmr.2019.10374.
Teymuori M, Yegdaneh A, Rabbani M. Effects of Piper nigrum fruit and Cinnamum zeylanicum bark alcoholic extracts, alone and in combination, on scopolamine-induced memory impairment in mice. Res Pharm Sci. 2021;16(5):474-481. DOI: 10.4103/1735-5362.323914.
Noguchi-Shinohara M, Ono K, Hamaguchi T, Nagai T, Kobayashi S, Komatsu J, et al. Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer’s disease progression. Sci Rep. 2020;10(1):18627,1-10. DOI: 10.1038/s41598-020-73729-2.
Gargouri B, Carstensen J, Bhatia HS, Huell M, Dietz GPH, Fiebich BL. Anti-neuroinflammatory effects of Ginkgo biloba extract EGb761 in LPS-activated primary microglial cells. Phytomedicine. 2018;44:45-55. DOI: 10.1016/j.phymed.2018.04.009.
Jiang Y, Gao H, Turdu G. Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer’s disease: a review. Bioorg Chem. 2017;75:50-61. DOI: 10.1016/j.bioorg.2017.09.004.
Siddiqui A, Shah Z, Jahan RN, Othman I, Kumari YJB. Mechanistic role of boswellic acids in Alzheimer’s disease: emphasis on anti-inflammatory properties. Biomed Pharmacother. 2021;144:112250,1-11. DOI: 10.1016/j.biopha.2021.112250.
Patil SM, Ramu R, Shirahatti PS, Shivamallu C, Amachawadi RG. A systematic review on ethnopharmacology, phytochemistry and pharmacological aspects of Thymus vulgaris Linn. Heliyon. 2021;7(5):e07054,1-22. DOI: 10.1016/j.heliyon.2021.e07054.
Soheili M, Salami M. Lavandula angustifolia biological characteristics: an in vivo study. J Cell Physiol. 2019;234(9):16424-16430. DOI: 10.1002/jcp.28311.
Yegdaneh A, Saeedi A, Shahmiveh T, Vaseghi G. The effect of Sargassum glaucescens from the Persian Gulf on neuropathy pain induced by paclitaxel in mice. Adv Biomed Res.2020;9:79,1-4. DOI: 10.4103/abr.abr_183_20.
Vaseghi G, Sharifi M, Dana N, Ghasemi A, Yegdaneh A. Cytotoxicity of Sargassum angustifolium partitions against breast and cervical cancer cell lines. Adv Biomed Res. 2018;7:43,1-4. DOI: 10.4103/abr.abr_259_16.
Lee JP, Kang MG, Lee JY, Oh JM, Baek SC, Leem HH, et al. Potent inhibition of acetylcholinesterase by sargachromanol I from Sargassum siliquastrum and by selected natural compounds. Bioorg Chem. 2019;89:103043,1-40. DOI: 10.1016/j.bioorg.2019.103043.
Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Res. 2019;29(10):787-803. DOI: 10.1038/s41422-019-0216-x.
Yende SR, Arora SK, Ittadwar AM. Antioxidant and cognitive enhancing activities of Sargassum ilicifolium and Padina tetrastromatica in scopolamine treated mice. J Biol Act Prod Nat. 2021;11(1):11-2. DOI: 10.1080/22311866.2020.1871071.
Saraswati, Giriwono PE, Iskandriati D, Tan CP, Andarwulan N. Sargassum seaweed as a source of anti-inflammatory substances and the potential insight of the tropical species: a review. Mar Drugs. 2019;17(10):590,1-35. DOI: 10.3390/md17100590.
Jiang CS, Wang YY, Song JT, Yu JH. Acylphloroglucinols as kinase inhibitors from Sargassum nigrifoloides. J Asian Nat Prod Res. 2019;21(7):619-626. DOI: 10.1080/10286020.2018.1463996.
Seong SH, Ali MY, Kim HR, Jung HA, Choi JS. BACE1 inhibitory activity and molecular docking analysis of meroterpenoids from Sargassum serratifolium. Bioorg Med Chem. 2017;25(15):3964-3970.DOI: 10.1016/j.bmc.2017.05.033.
Lee JP, Kang MG, Lee JY, Oh JM, Baek SC, Leem HH, et al. Potent inhibition of acetylcholinesterase by sargachromanol I from Sargassum siliquastrum and by selected natural compounds. Bioorg Chem. 2019;89:103043,1-41. DOI: 10.1016/j.bioorg.2019.103043.
Bogie J, Hoeks C, Schepers M, Tiane A, Cuypers A, Leijten F, et al. Dietary Sargassum fusiforme improves memory and reduces amyloid plaque load in an Alzheimer’s disease mouse model. Sci Rep. 2019;9(1):1-16. DOI: 10.1038/s41598-0 19-41399-4.
Everette JD, Bryant QM, Green AM, Abbey YA, Wangila GW, Walker RB. Thorough study of reactivity of various compound classes toward the Folin-Ciocalteu reagent. J Agric Food Chem. 2010;58(14):8139-8144. DOI: 10.1021/jf1005935.
Safavi M, Hosseini-Sharifabad A, Seyed-Yousefi Y, Rabbani M. Protective effects of citicoline and benfotiamine each alone and in combination on streptozotocin-induced memory impairment in mice. Clin Psychopharmacol Neurosci. 2020;18(1):81-92. DOI: 10.9758/cpn.2020.18.1.81.
Odubanjo VO, Ibukun EO, Oboh G, Adefegha SA. Aqueous extracts of two tropical ethnobotanicals (Tetrapleura tetraptera and Quassia undulata) improved spatial and non-spatial working memories in scopolamine-induced amnesic rats: influence of neuronal cholinergic and antioxidant systems. Biomed Pharmacother. 2018;99:198-204. DOI: 10.1016/j.biopha.2018.01.043.
Al-Zahrani Y, Sattar M, Al-Harthi SE, Alkreathy H. Neuroprotective effect of different doses of vitamine D3 in diabetic-induced alzheimer rat model. J Pharm Res Int. 2019;26(2):1-11. DOI: 10.9734/jpri/2019/v26i230132.
Vaseghi G, Rabbani M, Hajhashemi V. The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice. Res Pharm Sci. 2013;8(1):59-64.PMID: 24459477.
Alaei H, Moloudi R, Sarkaki AR. Effects of treadmill running on mid-term memory and swim speed in the rat with Morris water maze test. J Bodyw Mov Ther. 2008;12(1):72-75. DOI: 10.1016/j.jbmt.2007.05.004.
Sattayasai J, Chaonapan P, Arkaravichie T, Soi-Ampornkul R, Junnu S, Charoensilp P, et al. Protective effects of mangosteen extract on H2O2-induced cytotoxicity in SK-N-SH cells and scopolamine-induced memory impairment in mice. J Pone. 2013;8(12):e85053,1-13. DOI: 10.1371/journal.pone.0085053.
Sambeth A, Riedel WJ, Smits LT, Blokland A. Cholinergic drugs affect novel object recognition in rats: relation with hippocampal EEG. Eur J Pharmacol. 2007;572(2-3):151-159. DOI: 10.1016/j.ejphar.2007.06.018.
Cozzolino R, Guaraldi D, Giuliani A, Ghirardi O, Ramacci MT, Angelucci L. Effects of concomitant nicotinic and muscarinic blockade on spatial memory disturbance in rats are purely additive: evidence from the Morris water task. Physiol Behav. 1994;56(1):111-114. DOI: 10.1016/0031-9384(94)90267-4.
Smith JV, Luo Y. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis. 2003;5(4):287-300. DOI: 10.3233/JAD-2003-5404.
Kim EJ, Jung IH, Van Le TK, Jeong JJ, Kim NJ, Kim DH. Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice. J Ethnopharmacol. 2013;146(1):294-299. DOI: 10.1016/j.jep.2012.12.047.
Lueptow LMJJ. Novel object recognition test for the investigation of learning and memory in mice. J Vis Exp. 2017;(126):e55718,1-9.DOI: 10.3791/55718.
Hammond RS, Tull LE, Stackman RW. On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem. 2004;82(1):26-34. DOI: 10.1016/j.nlm.2004.03.005.
Yin Y, Ren Y, Wu W, Wang Y, Cao M, Zhu Z, et al. Protective effects of bilobalide on Aβ25-35 induced learning and memory impairments in male rats. Pharmacol Biochem Behav. 2013;106:77-84. DOI: 10.1016/j.pbb.2013.03.005.
Jain NK, Patil CS, Kulkarni SK, Singh A. Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice. Behav Brain Res. 2002;133(2):369-376. DOI: 10.1016/S0166-4328(02)00025-6.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.